Growth Metrics

Rockwell Medical (RMTI) Short-term Investments (2016 - 2026)

Rockwell Medical filings provide 16 years of Short-term Investments readings, the most recent being $14.3 million for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 140.51% to $14.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.3 million, a 140.51% increase, with the full-year FY2025 number at $14.3 million, up 140.51% from a year prior.
  • Short-term Investments hit $14.3 million in Q4 2025 for Rockwell Medical, up from $10.1 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $14.6 million in Q3 2022 to a low of $2.0 million in Q4 2023.
  • Median Short-term Investments over the past 5 years was $5.9 million (2023), compared with a mean of $7.8 million.
  • Biggest five-year swings in Short-term Investments: crashed 82.86% in 2023 and later surged 204.3% in 2024.
  • Rockwell Medical's Short-term Investments stood at $9.2 million in 2021, then grew by 24.37% to $11.4 million in 2022, then crashed by 82.86% to $2.0 million in 2023, then surged by 204.3% to $5.9 million in 2024, then skyrocketed by 140.51% to $14.3 million in 2025.
  • The last three reported values for Short-term Investments were $14.3 million (Q4 2025), $10.1 million (Q3 2025), and $5.9 million (Q2 2025) per Business Quant data.